SRPT logo

SRPT

Sarepta Therapeutics Inc.

$20.72
+$0.38(+1.87%)
47
Overall
60
Value
36
Tech
47
Quality
Market Cap
$1.85B
Volume
1.87M
52W Range
$10.42 - $120.05
Target Price
$21.43

Latest News for SRPT

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Danaher (DHR) and BridgeBio Pharma (BBIO)
Brian Andersona day agoFeb 02, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT – Research Report), Dan......

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT) and Arcutis Biotherapeutics (ARQT)
Christine Brown8 days agoJan 26, 2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT – Research Report) and Arcutis Biother......

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sarepta Therapeutics (SRPT) and InMode (INMD)
Christine Brown8 days agoJan 26, 2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT – Research Report) and InMode (INMD – ......

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Vaxcyte (PCVX)
Brian Anderson11 days agoJan 23, 2026

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report) and Va......

Analysts Conflicted on These Healthcare Names: Apellis Pharmaceuticals (APLS), Sarepta Therapeutics (SRPT) and Mereo Biopharma Group Plc (MREO)
Brian Anderson21 days agoJan 13, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apellis Pharmaceuticals (APLS – Research Report), ......

Analysts Have Conflicting Sentiments on These Healthcare Companies: Establishment Labs Holdings (ESTA), Sarepta Therapeutics (SRPT) and Insmed (INSM)
Brian Anderson21 days agoJan 13, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Establishment Labs Holdings (ESTA – Research Repor......

Wells Fargo Remains a Buy on Sarepta Therapeutics (SRPT)
TipRanks Auto-Generated Intelligence Newsdeska month agoJan 05, 2026

Wells Fargo analyst Yanan Zhu maintained a Buy rating on Sarepta Therapeutics today and set a price target of $45.00. According to TipRanks, Zhu is......

News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.

ABCD
1SymbolPriceChangeVol
2SRPT$20.72+1.9%1.87M
3
4
5
6

Get Sarepta Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.